- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06276595
Telling Our Daughters Our Story (TODOS)
Telling Our Daughters Our Story: Pre-Conception Health Program for American Indian Girls as They Transition to Adulthood
Study Overview
Status
Conditions
Detailed Description
The investigators will employ a randomized controlled trial (RCT) design to assess the preliminary impact of the TODOS program on many factors, including improving cultural knowledge, family engagement in Apache culture, mother daughter communication, self-esteem, self-efficacy, social support, attitudes about risky behaviors, and knowledge of reproductive health and substance use. Participants will be caregivers of girls ages 8-11 years.
The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and the girl's female caregivers. Five of the 11 sessions will be taught to small groups of girls and the girl's mothers, and 6 of the sessions will be taught to individual girl/female caregivers' dyads. The choice to use a mix of group- and home-based sessions is based on findings from the formative phase about preference that certain topics be taught in groups, and certain topics be taught in individual dyads. Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC).
The investigators will enroll up to 94 dyads into four cohorts, each consisting of 18-26 dyads. Dyads will receive either the TODOS program or a control condition. The control condition will consist of 3 group sessions delivered monthly for three months. The investigators will evaluate the TODOS program's feasibility through process data including attendance forms and session summary feedback forms completed by the FHCs. The investigators will assess program acceptability immediately after program completion through implementation assessments completed by caregiver and children participants. The investigators will assess the program's impact on key outcomes immediately after program implementation, 6-month and 12-month post program implementation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Whiteriver, Arizona, United States, 85941
- White Mountain Apache Center for Indigenous Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria for Caregivers:
- Female > 18 years of age
- Self-identify as Apache
- Be a caregiver of a girl 8-11 years old who is available to enroll in the study
- Living within 50 miles of the Whiteriver or Fort Apache, Arizona Johns Hopkins program offices
- Willing to complete all implementation and follow-up assessments
- Willing to be randomized
- Speaks and reads English
Inclusion Criteria for Child Participants:
- Female, 8-11 years old
- Have a caregiver enrolled in the study
- Living within 50 miles of the Whiteriver or Fort Apache, Arizona Johns Hopkins program offices
- Willing to be randomized
- Willing to complete all implementation and follow-up assessments
- Speaks and reads English
- Not cognitively or visually impaired (able to complete questionnaires)
Exclusion Criteria:
- Inability to participate in full intervention or evaluation (e.g., planned move, residential treatment, cognitive impairment, etc.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TODOS Intervention
Participants in the TODOS Intervention Group will receive the intervention "Nowhi Isdza bit Nadagoldi": Telling Our Daughters Our Story.
They will receive 11 intervention sessions of 60-90 minutes over 11 weeks.
|
The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and their female caregivers.
Five of the 11 sessions will be taught to small groups, and 6 of the Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC).
Group sessions will take place at a local community center in a private room.
|
|
Other: Control condition - 3 Monthly Group Activities in the Community
Children and their female caregivers randomized to the control group will receive 3 group sessions delivered monthly for three months.
The first group session will occur at a community center and will consist of a meal and ice breaker activities.
The second group session will consist of going to a movie at the local movie theatre.
The third group session will consist of going bowling at the local bowling alley.
|
The control condition consists of 3 group sessions delivered monthly for three months.
The first group session will occur at a community center and will consist of a meal and ice breaker activities.
The second group session will consist of going to a movie at the local movie theatre The third group session will consist of going bowling at the local bowling alley.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in child cultural knowledge score on knowledge assessment
Time Frame: Baseline, 11 weeks, 6 months, 12 months
|
Using a questionnaire developed by the study team, investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a knowledge assessment completed by the child.
This is a 4- question assessment that is on a 5-point Likert scale (score: 0-20) A higher score indicates higher (greater) knowledge.
|
Baseline, 11 weeks, 6 months, 12 months
|
|
Change in average score on risky behaviors assessment
Time Frame: Baseline, 11 weeks, 6 months, 12 months
|
Using a questionnaire developed by the study team, the investigators will assess the impact of the TODOS program on child attitudes related to risky behaviors via a 6-item assessment on a 5-point Likert scale (score: 0-30).
Investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a knowledge assessment completed by the child.
A higher score indicates better attitudes (less endorsement of) risk behaviors.
|
Baseline, 11 weeks, 6 months, 12 months
|
|
Change in child reproductive health knowledge via a reproductive health knowledge questionnaire
Time Frame: Baseline, 11 weeks, 6 months, 12 months
|
Using a questionnaire developed by the study team, investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a 3-question knowledge assessment completed by the child (score 0-100).
A higher score indicates more knowledge.
|
Baseline, 11 weeks, 6 months, 12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mary Barlow, PhD, Johns Hopkins Bloomberg School of Public Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00009466
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States